Cullinan Therapeutics (CGEM) Operating Margin (2021)
Cullinan Therapeutics (CGEM) has 1 years of Operating Margin data on record, last reported at 7.24% in Q1 2021.
- For Q1 2021, Operating Margin changed N/A year-over-year to 7.24%; the TTM value through Dec 2021 reached 358.73%, changed N/A, while the annual FY2021 figure was 358.73%, N/A changed from the prior year.
- Operating Margin reached 7.24% in Q1 2021 per CGEM's latest filing.
- Across five years, Operating Margin topped out at 7.24% in Q1 2021 and bottomed at 7.24% in Q1 2021.